ORGO · Organogenesis Holdings Inc. · Proposed Sales
$0.82
+0.01 (+1.30%)
At close · Nov 9
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$105.55M
Shares
129.80M
Volume · Nov 9
83.13K
Avg daily vol (3M)
879.14K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-12-16 | Glenn Nussdorf | Director, Stakeholder | 200,000 | 2025-12-16 | UBS Financial Services Inc |
| 2025-11-25 | Glenn Nussdorf | Director, Stakeholder | 200,000 | 2025-11-25 | UBS Financial Services Inc |
| 2025-11-24 | Glenn Nussdorf | Director, Stakeholder | 100,000 | 2025-11-24 | UBS Financial Services Inc |
| 2025-03-17 | Driscoll Michael Joseph | Director | 25,000 | 2025-03-04 | Merrill Lynch |
| 2024-12-06 | Gillheeney Gary S. | Officer | 380,000 | 2024-12-06 | Merrill Lynch |
| 2024-01-09 | RED Holdings, LLC | Shareholder is part of a control group | 2,000,000 | 2024-01-09 | UBS Financial Services Inc |
| 2024-01-09 | Albert Erani | Part of a control group of shareholders | 422,589 | 2024-01-09 | UBS Financial Services Inc |
Showing 1–7 of 7 filings
Key facts
CIK
1661181
CUSIP
68621F102
13F (30d)
53 filings
41 filers
Visit website
Investor relations